Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David Bienvenue
Observed names:
D.L. Bienvenue,
David L Bienvenue,
David L. Bienvenue
Institution:
Aptevo Therapeutics (United states)
Observed institutions:
Marquette University,
Utah State University,
University of Georgia,
Loyola University Chicago,
Medical College of Wisconsin,
Emergent BioSolutions (United States),
Aptevo Therapeutics (United states),
The Ohio State University,
Brandeis University
show all 9
ORCID:
0000-0002-6115-3102
Observed ORCID:
0000-0002-6115-3102
OpenAlex ID:
A5034579944
MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer
2016
·
Gabriela Hernandez-Hoyos
, Toddy Sewell
, et al.
·
Molecular Cancer Therapeutics
·
73
PDF
The 1.20 Å Resolution Crystal Structure of the Aminopeptidase from Aeromonas proteolytica Complexed with Tris
2002
·
William T Desmarais
, David L Bienvenue
, et al.
·
Structure
·
71
PDF
Substrate Specificity, Metal Binding Properties, and Spectroscopic Characterization of the DapE-Encoded N-Succinyl- l , l -Diaminopimelic Acid Desuccinylase from Haemophilus influenzae
2003
·
David L. Bienvenue
, Danuta M. Gilner
, et al.
·
Biochemistry
·
53
PDF
The high-resolution structures of the neutral and the low pH crystals of aminopeptidase from Aeromonas proteolytica
2006
·
William Desmarais
, David L. Bienvenue
, et al.
·
JBIC Journal of Biological Inorganic Chemistry
·
41
PDF
Spectroscopic and X-ray Crystallographic Characterization of Bestatin Bound to the Aminopeptidase from Aeromonas (Vibrio) proteolytica,
2004
·
Carin C. Stamper
, David L. Bienvenue
, et al.
·
Biochemistry
·
38
PDF
Slow-Binding Inhibition of the Aminopeptidase from Aeromonas proteolytica by Peptide Thiols: Synthesis and Spectroscopic Characterization
1999
·
Kristi M. Huntington
, David L. Bienvenue
, et al.
·
Biochemistry
·
37
PDF
The dapE-encoded N-Succinyl- l , l -Diaminopimelic Acid Desuccinylase from Haemophilus influenzae Is a Dinuclear Metallohydrolase
2003
·
Nathaniel J. Cosper
, David L. Bienvenue
, et al.
·
Journal of the American Chemical Society
·
36
Structural Evidence of a Major Conformational Change Triggered by Substrate Binding in DapE Enzymes: Impact on the Catalytic Mechanism
2017
·
Boguslaw Nocek
, Cory Reidl
, et al.
·
Biochemistry
·
30
Kinetic and spectroscopic characterization of the E134A- and E134D-altered dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase from Haemophilus influenzae
2006
·
Ryan Davis
, David Bienvenue
, et al.
·
JBIC Journal of Biological Inorganic Chemistry
·
30
PDF
Inhibition of the aminopeptidase from Aeromonas proteolytica by l-leucinethiol: kinetic and spectroscopic characterization of a slow, tight-binding inhibitor–enzyme complex
2000
·
David L Bienvenue
, Brian Bennett
, et al.
·
Journal of Inorganic Biochemistry
·
30
PDF
The aminopeptidase from Aeromonas proteolytica can function as an esterase
2001
·
David L. Bienvenue
, Rebecca S. Mathew
, et al.
·
JBIC Journal of Biological Inorganic Chemistry
·
26
The dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase from Haemophilus influenzae contains two active-site histidine residues
2008
·
Danuta M. Gillner
, David L. Bienvenue
, et al.
·
JBIC Journal of Biological Inorganic Chemistry
·
25
Abstract 1786: APVO436, a bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecule for redirected T-cell cytotoxicity, induces potent T-cell activation, proliferation and cytotoxicity with limited cytokine release
2018
·
Michael R. Comeau
, Robert E. Miller
, et al.
·
Cancer Research
·
22
Hydrolysis of Thionopeptides by the Aminopeptidase from Aeromonas proteolytica: Insight into Substrate Binding
2002
·
David L. Bienvenue
, Danuta Gilner
, et al.
·
Biochemistry
·
20
PDF
The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
2022
·
Michelle H. Nelson
, Sara Fritzell
, et al.
·
Molecular Cancer Therapeutics
·
14
A Novel Highly Potent Therapeutic Antibody Neutralizes Multiple Human Chemokines and Mimics Viral Immune Modulation
2012
·
Michelle L. Scalley-Kim
, Bruce W. Hess
, et al.
·
PLoS ONE
·
13
PDF
Abstract LB-199: APVO436, a bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecule for redirected T-cell cytotoxicity with limited cytokine release, is well tolerated in repeat dose toxicology studies in cynomolgus macaques
2019
·
Michael R. Comeau
, Rebecca Gottschalk
, et al.
·
Cancer Research
·
10
Abstract B111: Characterization of APVO436, a bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecule for redirected T-cell cytotoxicity, in preclinical models of AML and nonhuman primates
2018
·
Michael R. Comeau
, Robert E. Miller
, et al.
·
Molecular Cancer Therapeutics
·
6
Abstract 4062: A novel method for generating regulated cytokine therapeutics: Safety and activity of a conditionally active cLAG3-IL2 capable of delivering IL2 to LAG3+ cells while remaining inert on LAG3- cells
2024
·
Justin Killebrew
, Shannon Okada
, et al.
·
Cancer Research
·
5
Abstract LB-199: APVO436, a bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecule for redirected T-cell cytotoxicity with limited cytokine release, is well tolerated in repeat dose toxicology studies in cynomolgus macaques
2019
·
Michael R. Comeau
, Rebecca Gottschalk
, et al.
·
Immunology
·
4
851 Potent tumor-directed T cell activation and in vivo tumor inhibition induced by a 4–1BB x 5T4 ADAPTIR™ bispecific antibody
2020
·
Michelle Nelson
, Robert Miller
, et al.
·
Journal for ImmunoTherapy of Cancer
·
3
Abstract 4995: anti-ROR1 x anti-CD3 ADAPTIR™ molecule, ES425, redirects T-cell cytotoxicity and inhibits tumor growth in preclinical models of triple-negative breast cancer
2016
·
John W. Blankenship
, Lynda Misher
, et al.
·
Cancer Research
·
3
Abstract 597: Bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecules for redirected T-cell cytotoxicity in hematological malignancies
2017
·
Michael R. Comeau
, Danielle Mitchell
, et al.
·
Cancer Research
·
2
ProteinTracker: an application for managing protein production and purification
2012
·
Stefan C Ponko
, David Bienvenue
·
BMC Research Notes
·
2
PDF
633 Dual-targeting of 4–1BB and OX40 with an ADAPTIR™ bispecific antibody enhances anti-tumor responses to solid tumor
2020
·
Michelle Nelson
, Robert Miller
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
Show more works
View as search
Works count:
56
Citation count:
596
H-index:
14
I10-index:
17
Year
Topic
Type